Clinical Trial Units
At any one time the University of Oxford sponsors around 1,000 academic designed and led clinical research studies within the EU of which about 150 are interventional trials ranging from phase I to phase IV. The University sponsors approximately 350 further studies outside the EU, largely through its Centre for Tropical Medicine and Global Health.
Our Clinical Trial Units
We run five UKCRC fully-registered specialist clinical trials units, supporting national, multinational and multicentre trials, ranging from phase I to phase IV.
Clinical Trial Management
Careers in clinical trial management, details of training and development courses and guidance for anyone interested in pursuing a career in trial management.
Participate in a Clinical Trial
If you are interested in participating in a clinical trial, this page contains links to Clinical Trial Units across the University and NHS that maybe recruiting participants.
Latest Clinical Trial News
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
17 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
The GEKO trial launches to bridge the gap in knee osteoarthritis care
30 October 2025
A new multicentre trial to evaluate a minimally invasive treatment for patients with knee osteoarthritis could transform the way knee osteoarthritis is managed, potentially improving quality of life for patients long before surgery becomes necessary.
First volunteers receive Rift Valley fever vaccine in Kenya Phase II trial
15 August 2025
On 8 July 2025, researchers at the KEMRI-Wellcome Trust Research Programme began the Phase II trial of the ChAdOx1 RVF vaccine in Kilifi, Kenya—the most advanced Rift Valley fever vaccine study in an outbreak-prone region. Led by Oxford University and funded by CEPI, this milestone brings us closer to a licensed vaccine for protecting lives and livelihoods.